{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:49:03Z","timestamp":1781585343291,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM136300, RF1AG059723, R01AG080016"],"award-info":[{"award-number":["R35GM136300, RF1AG059723, R01AG080016"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Monoclonal antibodies that recognize conformational epitopes in protein aggregates are important for research, diagnostic, and therapeutic applications related to neurodegenerative disorders such as Alzheimer\u2019s and Parkinson\u2019s diseases. Unfortunately, it remains challenging to discover and engineer high-quality conformational antibodies that are specific for protein aggregates and possess optimal combinations of three key binding properties, namely high affinity, high conformational specificity, and low off-target binding. Here we report a directed evolution approach for generating high-quality conformational antibodies against Alzheimer\u2019s A\u03b2 fibrils in the native IgG format. Our directed evolution approach uses targeted mutagenesis, yeast surface display, cell sorting, and deep sequencing to identify antibody candidates with optimized binding properties. Notably, we find that this approach yields robust isolation of IgGs with higher affinity, higher conformational specificity, and lower off-target binding than multiple clinical-stage A\u03b2 antibodies, including aducanumab and crenezumab. This antibody engineering platform can be readily applied to generate conformational antibodies against diverse types of peptide and protein aggregates linked to human diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1655893","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:28:24Z","timestamp":1760333304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Directed evolution of drug-like A\u03b2 conformation-specific antibodies"],"prefix":"10.3389","volume":"16","author":[{"given":"Alec A.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Zupancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Makowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Gerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena I.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human disease: A summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0560-11.2011","article-title":"Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases","volume":"31","author":"Kanaan","year":"2011","journal-title":"J Neurosci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100508","article-title":"Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity","volume":"296","author":"Desai","year":"2021","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-025-01881-9","article-title":"Facile generation of drug-like conformational antibodies specific for amyloid fibrils","volume":"21","author":"Desai","year":"2025","journal-title":"Nat Chem Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nly010","article-title":"Detection of Alzheimer disease (AD)-specific tau pathology in AD and nonAD tauopathies by immunohistochemistry with novel conformation-selective tau antibodies","volume":"77","author":"Gibbons","year":"2018","journal-title":"J Neuropathology Exp Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.004731","article-title":"Nature-inspired design and evolution of anti-amyloid antibodies","volume":"294","author":"Julian","year":"2019","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiol Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/bit.27610","article-title":"Directed evolution of conformation-specific antibodies for sensitive detection of polypeptide aggregates in therapeutic drug formulations","volume":"118","author":"Lou","year":"2021","journal-title":"Biotechnol Bioeng"},{"key":"B9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol Neurodegener"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.594846","article-title":"Monoclonal antibodies against A\u03b242 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain","volume":"289","author":"Hatami","year":"2014","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/bit.26994","article-title":"Sensitive detection of glucagon aggregation using amyloid fibril-specific antibodies","volume":"116","author":"Stimple","year":"2019","journal-title":"Biotechnol Bioeng"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.3463","article-title":"Development of a pan-tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregates","volume":"40","author":"McArthur","year":"2024","journal-title":"Biotechnol Prog"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5109-14.2015","article-title":"A human monoclonal IgG that binds A\u03b2 Assemblies and diverse amyloids exhibits anti-amyloid activities","volume":"35","author":"Levites","year":"2015","journal-title":"J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","article-title":"Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases","volume":"9","author":"Altay","year":"2023","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2016.08.019","article-title":"abYsis: integrated antibody sequence and structure\u2014Management, analysis, and prediction","volume":"429","author":"Swindells","year":"2017","journal-title":"J Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12866-015-0450-4","article-title":"Phasing amplicon sequencing on Illumina Miseq for robust environmental microbial community analysis","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185056","article-title":"BBMerge - Accurate paired shotgun read merging via overlap","volume":"12","author":"Bushnell","year":"2017","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/12.2.135","article-title":"Using substitution probabilities to improve position-specific scoring matrices","volume":"12","author":"Henikoff","year":"1996","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.12091","article-title":"Detection of conserved segments in proteins: iterative scanning of sequence databases with alignment blocks","volume":"91","author":"Tatusov","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"btad446","DOI":"10.1093\/bioinformatics\/btad446","article-title":"Position-Specific Enrichment Ratio Matrix scores predict antibody variant properties from deep sequencing data","volume":"39","author":"Smith","year":"2023","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1164080","article-title":"Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates","volume":"14","author":"Zupancic","year":"2023","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1951426","DOI":"10.1080\/19420862.2021.1951426","article-title":"Highly sensitive detection of antibody nonspecific interactions using flow cytometry","volume":"13","author":"Makowski","year":"2021","journal-title":"mAbs"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzt047","article-title":"Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool","volume":"26","author":"Xu","year":"2013","journal-title":"Protein Eng Des Sel"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.01.093","article-title":"The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies","volume":"377","author":"Birtalan","year":"2008","journal-title":"J Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401786101","article-title":"Synthetic antibodies from a four-amino-acid code: A dominant role for tyrosine in antigen recognition","volume":"101","author":"Fellouse","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1039\/b927393j","article-title":"The functional capacity of the natural amino acids for molecular recognition","volume":"6","author":"Birtalan","year":"2010","journal-title":"Mol Biosyst"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzz002","article-title":"Net charge of antibody complementarity-determining regions is a key predictor of specificity","volume":"31","author":"Rabia","year":"2018","journal-title":"Protein Eng Des Sel"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00257","article-title":"Physicochemical rules for identifying monoclonal antibodies with drug-like specificity","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol Pharm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1075109","article-title":"The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies","volume":"7","author":"Datta-Mannan","year":"2015","journal-title":"mAbs"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.783837","article-title":"Arginine mutations in antibody complementarity-determining regions display context-dependent affinity\/specificity trade-offs","volume":"292","author":"Tiller","year":"2017","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bej.2018.06.003","article-title":"Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility","volume":"137","author":"Rabia","year":"2018","journal-title":"Biochem Eng J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1016\/j.celrep.2019.08.056","article-title":"Affinity maturation enhances antibody specificity but compromises conformational stability","volume":"28","author":"Shehata","year":"2019","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015501","article-title":"An \u201cepitomic\u201d analysis of the specificity of conformation-dependent, anti-A\u03b2; amyloid monoclonal antibodies","volume":"296","author":"Reyes-Ruiz","year":"2021","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12070","article-title":"Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer\u2019s disease","volume":"40","author":"Allen","year":"2014","journal-title":"Neuropathology Appl Neurobiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-968-6_26","article-title":"Affinity maturation of single-domain antibodies by yeast surface display","volume":"911","author":"Koide","year":"2012","journal-title":"Methods Mol Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.170297297","article-title":"Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity","volume":"97","author":"Boder","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1803646","DOI":"10.1080\/19420862.2020.1803646","article-title":"Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR","volume":"12","author":"Simons","year":"2020","journal-title":"mAbs"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00602-1","article-title":"Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries","volume":"546","author":"van den Beucken","year":"2003","journal-title":"FEBS Lett"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2025.05.013","article-title":"Bright sorting yields drug-like anti-amyloid antibodies","volume":"46","author":"Li","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-2285-8_22","article-title":"Isolating anti-amyloid antibodies from yeast-displayed libraries","volume-title":"Methods Mol Biol.","author":"Desai","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am J Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402043","article-title":"Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer\u2019s disease","volume":"9","author":"Roher","year":"2003","journal-title":"Mol Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s40478-023-01694-8","article-title":"Cryo-EM structures of A\u03b240 filaments from the leptomeninges of individuals with Alzheimer\u2019s disease and cerebral amyloid angiopathy","volume":"11","author":"Yang","year":"2023","journal-title":"Acta Neuropathologica Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1043503","article-title":"High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice","volume":"7","author":"Kelly","year":"2015","journal-title":"mAbs"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.4.15786","article-title":"Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4","volume":"3","author":"Bumbaca","year":"2011","journal-title":"mAbs"},{"key":"B49","doi-asserted-by":"publisher","first-page":"38644","DOI":"10.1038\/srep38644","article-title":"Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo","volume":"6","author":"Dobson","year":"2016","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114801","article-title":"Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions","volume":"43","author":"Chen","year":"2024","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655893\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:28:25Z","timestamp":1760333305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1655893\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2025.1655893"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1655893","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"article-number":"1655893"}}